Related Experiment Videos
[Immunodepression. Its predisposing role in the development of multiple primary carcinomas]
La Nouvelle Presse Medicale
|May 25, 1974
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Paranasal sinus carcinoma].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2010
Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2007
[Preliminary results of the assessment of intensity modulated radiotherapy (IMRT) for prostatic and head and neck tumors (STIC 2001)].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2005
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2005
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.
British journal of cancer·2004
[Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2004
[Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
La Nouvelle presse medicale·1982
[Plasmapheresis in autoimmune syndromes. Indications. Results].
La Nouvelle presse medicale·1982
[Relation between monoclonal gammopathy and hepatobiliary disease].
La Nouvelle presse medicale·1982
Comparative assessment of serum adipokine and trace element alterations in papillary thyroid carcinoma.
Journal of Taibah University Medical Sciences·2026
Semaglutide attenuates a proteomics-based dementia risk signature in older adults with overweight or obesity and cardiovascular disease without diabetes: A post hoc analysis of the SELECT phase 3 trial.
Alzheimer's & dementia (Amsterdam, Netherlands)·2026